(Q53968748)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

N Sasaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

E Kusano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Nemoto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

O Iimura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C Ito

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

S Takeda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K Yano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

E Tsuda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Y Asano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Yukio Ando

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

853-858

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Effects of deflazacort on aspects of bone formation in cultures of intact calvariae and osteoblast-enriched cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Mechanisms of glucocorticoid action in bone cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Bone histomorphometry in glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

New developments in biochemical markers for osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Effects of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: possible mechanisms of glucocorticoid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Prevention of corticosteroid-induced osteoporosis by alfacalcidol

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

The course of biochemical parameters of bone turnover during treatment with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Glucocorticoid osteoporosis--mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Acute effects of etidronate on glucocorticoid-induced bone degradation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2802%2900742-1

7 January 2021

10.1016/S8756-3282(02)00742-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052453%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference